206 related articles for article (PubMed ID: 19860592)
1. Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients.
El-Chennawi FA; Mosaad YM; Habib HM; El-Degheidi T
Immunol Invest; 2009; 38(8):839-50. PubMed ID: 19860592
[TBL] [Abstract][Full Text] [Related]
2. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
Almogren A
Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
[TBL] [Abstract][Full Text] [Related]
3. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
[TBL] [Abstract][Full Text] [Related]
4. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
Dipti TR; Azam MS; Sattar MH; Rahman SA
Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
[TBL] [Abstract][Full Text] [Related]
5. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
[TBL] [Abstract][Full Text] [Related]
7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis.
Copple SS; Sawitzke AD; Wilson AM; Tebo AE; Hill HR
Am J Clin Pathol; 2011 May; 135(5):678-84. PubMed ID: 21502422
[TBL] [Abstract][Full Text] [Related]
9. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
11. Double stranded DNA antibody estimation for the diagnosis of systematic lupus erythematosus [corrected].
Mohanalingam U; Mathai E; Sridharan G
Indian J Pathol Microbiol; 1993 Jul; 36(3):265-7. PubMed ID: 8093130
[TBL] [Abstract][Full Text] [Related]
12. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test.
Conrad K; Ittenson A; Reinhold D; Fischer R; Roggenbuck D; Büttner T; Bosselmann HP; Steinbach J; Schössler W
Ann N Y Acad Sci; 2009 Sep; 1173():180-5. PubMed ID: 19758148
[TBL] [Abstract][Full Text] [Related]
13. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
[TBL] [Abstract][Full Text] [Related]
14. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
15. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
Lüthke K; Conrad K; Frank KH
Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
[TBL] [Abstract][Full Text] [Related]
16. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
17. The incidence of ANA and ETI-dsDNA detected by enzyme immunoassays and indirect immunofluorescence assay (IFA).
Aganovic-Musinovic I; Prljaca-Zecevic L; Subasic D
Med Arh; 2010; 64(2):68-70. PubMed ID: 20514767
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.
Marin GG; Cardiel MH; Cornejo H; Viveros ME
J Clin Rheumatol; 2009 Oct; 15(7):325-9. PubMed ID: 20009966
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of indirect immunofluorescence assay and ELISA for detecting antinuclear antibodies and anti-double-stranded DNA antibodies].
Qin X; Tao X; Chen ZJ; Jiang JQ; Xu MH; Li RL; Li TJ; Lin FQ; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):472-5. PubMed ID: 19304528
[TBL] [Abstract][Full Text] [Related]
20. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
